Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 15% Improvement Relative Risk Ventilation 19% ICU admission 28% Vitamin D for COVID-19  Lohia et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 183 patients in the USA Lower mortality (p=0.56) and ventilation (p=0.48), not sig. c19early.org Lohia et al., American J. Physiology-E.., Mar 2021 Favors vitamin D Favors control

Exploring the link between vitamin D and clinical outcomes in COVID-19

Lohia et al., American Journal of Physiology-Endocrinology and Metabolism, doi:10.1152/ajpendo.00517.2020
Mar 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Retrospective 270 patients with vitamin D levels measured in the last year, showing no significant difference in outcomes based on vitamin D levels or vitamin D supplementation.
This is the 52nd of 196 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 11,637 vigintillion).
risk of death, 14.7% lower, RR 0.85, p = 0.56, high D levels 88, low D levels 95, odds ratio converted to relative risk, control prevalence approximated with overall prevalence, >30 ng/mL vs. <20 ng/mL, >30 ng/mL group size approximated.
risk of mechanical ventilation, 18.9% lower, RR 0.81, p = 0.48, high D levels 88, low D levels 95, odds ratio converted to relative risk, control prevalence approximated with overall prevalence, >30 ng/mL vs. <20 ng/mL, >30 ng/mL group size approximated.
risk of ICU admission, 28.5% lower, RR 0.72, p = 0.17, high D levels 88, low D levels 95, odds ratio converted to relative risk, control prevalence approximated with overall prevalence, >30 ng/mL vs. <20 ng/mL, >30 ng/mL group size approximated.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Lohia et al., 4 Mar 2021, retrospective, USA, peer-reviewed, 4 authors.
This PaperVitamin DAll
Exploring the link between vitamin D and clinical outcomes in COVID-19
Prateek Lohia, Paul Nguyen, Neel Patel, Shweta Kapur
American Journal of Physiology-Endocrinology and Metabolism, doi:10.1152/ajpendo.00517.2020
The immunomodulating role of vitamin D might play a role in COVID-19 disease. We studied the association between vitamin D and clinical outcomes in COVID-19 patients. This is a retrospective cohort study on COVID-19 patients with documented vitamin D levels within the last year. Vitamin D levels were grouped as ! 20 ng/mL or < 20 ng/mL. Main outcomes were mortality, need for mechanical ventilation, new DVT or pulmonary embolism, and ICU admission. A total of 270 patients (mean ± SD) age, 63.81 (14.69) years); 117 (43.3%) males; 216 (80%) Blacks; 139 (51.5%) in 65 and older age group were included. Vitamin D levels were less than 20 ng/mL in 95 (35.2%) patients. During admission, 72 patients (26.7%) died, 59 (21.9%) needed mechanical ventilation, and 87 (32.2%) required ICU. Vitamin D levels showed no significant association with mortality (OR = 0.69; 95% CI, 0.39-1.24; P = 0.21), need for mechanical ventilation (OR = 1.23; 95% CI, 0.68-2.24; P = 0.49), new DVT or PE(OR= 0.92; 95% CI, 0.16-5.11; P = 1.00) or ICU admission (OR = 1.38; 95% CI, 0.81-2.34; P = 0.23). We did not find any significant association of vitamin D levels with mortality, the need for mechanical ventilation, ICU admission and the development of thromboembolism in COVID-19 patients. NEW & NOTEWORTHY Low vitamin D has been associated with increased frequency and severity of respiratory tract infections in the past. Current literature linking clinical outcomes in COVID-19 with low vitamin D is debatable. This study evaluated the role of vitamin D in severe disease outcomes among COVID-19 patients and found no association of vitamin D levels with mortality, the need for mechanical ventilation, ICU admission, and thromboembolism in COVID-19.
AUTHOR CONTRIBUTIONS P.L., P.N., and N.P. conceived and designed research; P.L. and S.K. analyzed data; P.L. and S.K. interpreted results of experiments; P.L., P.N., N.P., and S.K. prepared figures; P.L., P.N., and S.K. drafted manuscript; P.L., P.N., N.P., and S.K. edited and revised manuscript; P.L., P.N., N.P., and S.K. approved final version of manuscript.
References
Adams, Ren, Liu, Chun, Lagishetty et al., Vitamin D-directed rheostatic regulation of monocyte antibacterial responses, J Immunol, doi:10.4049/jimmunol.0803736
Anderson, Geleris, Anderson, Zucker, Nobel et al., Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study, Ann Intern Med, doi:10.7326/M20-3214
Blondon, Rodabough, Budrys, Johnson, Berger et al., The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism: from the Women's Health Initiative Randomized Controlled Trial, Thromb Haemost, doi:10.1160/TH14-05-0478
Braun, Chang, Mahadevappa, Gibbons, Liu et al., Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill, Crit Care Med, doi:10.1097/CCM.0b013e318206ccdf
Brodin, Lerstad, Grimnes, Braekkan, Vik et al., Serum levels of vitamin D are not associated with future risk of venous thromboembolism: the Tromsø study, Thromb Haemost, doi:10.1160/TH12-10-0728
Brøndum-Jacobsen, Benn, Tybjaerg-Hansen, Nordestgaard, 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants, J Thromb Haemost, doi:10.1111/jth.12118
Cannell, Vieth, Umhau, Holick, Grant et al., Epidemic influenza and vitamin D, Epidemiol Infect, doi:10.1017/S0950268806007175
Cantorna, Snyder, Lin, Yang, Vitamin D and 1,25(OH)2D regulation of T cells, Nutrients, doi:10.3390/nu7043011
Carpagnano, Lecce, Quaranta, Zito, Buonamico et al., Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest, doi:10.1007/s40618-020-01370-x
Charan, Goyal, Saxena, Yadav, Vitamin D for prevention of respiratory tract infections: a systematic review and meta-analysis, J Pharmacol Pharmacother, doi:10.4103/0976-500X.103685
Charoenngam, Holick, Immunologic effects of vitamin D on human health and disease, Nutrients, doi:10.3390/nu12072097
D'avolio, Avataneo, Manca, Cusato, Nicol O et al., 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359
Dancer, Parekh, Lax, Souza, Zheng et al., Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax, doi:10.1136/thoraxjnl-2014-206680
De Haan, Groeneveld, De Geus, Egal, Struijs, Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis, Crit Care, doi:10.1186/s13054-014-0660-4
Forrest, Stuhldreher, Prevalence and correlates of vitamin D deficiency in US adults, Nutr Res, doi:10.1016/j.nutres.2010.12.001
Ginde, Mansbach, Camargo, Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey, Arch Intern Med, doi:10.1001/archinternmed.2008.560
Grasselli, Zangrillo, Zanella, Antonelli, Cabrini et al., Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy, JAMA, doi:10.1001/jama.2020.5394
Greiller, Martineau, Modulation of the immune response to respiratory viruses by vitamin D, Nutrients, doi:10.3390/nu7064240
Hansdottir, Monick, Hinde, Lovan, Look et al., Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense, J Immunol, doi:10.4049/jimmunol.181.10.7090
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.04.050
Hooper, Nápoles, Erez-Stable, COVID-19 and racial/ethnic disparities, JAMA, doi:10.1001/jama.2020.8598
Hwang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China, JAMA, doi:10.1001/jama.2020.1585
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res, doi:10.1007/s40520-020-01570-8
Janssens, Bouillon, Claes, Carremans, Lehouck et al., Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene, Thorax, doi:10.1136/thx.2009.120659
Jeffery, Burke, Mura, Zheng, Qureshi et al., 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, J Immunol, doi:10.4049/jimmunol.0803217
Jolliffe, Griffiths, Martineau, Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2012.11.017
Khunti, Singh, Pareek, Hanif, Is ethnicity linked to incidence or outcomes of covid-19?, BMJ, doi:10.1136/bmj.m1548
Klok, Kruip, Van Der Meer, Arbous, Gommers et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res, doi:10.1016/j.thromres.2020.04.013
Kohlmeier, Avoidance of vitamin D deficiency to slow the COVID-19 pandemic, BMJ Nutr Prev Health, doi:10.1136/bmjnph-2020-000096
Laird, Rhodes, Kenny, Vitamin D and inflammation: potential implications for severity of Covid-19, Ir Med J
Lee, Eisman, Center, Vitamin D deficiency in critically ill patients, N Engl J Med, doi:10.1056/NEJMc0809996
Lei, Zhang, Cheng, Lee, Mechanisms of action of vitamin D as supplemental therapy for pneumocystis pneumonia, Antimicrob Agents Chemother, doi:10.1128/AAC.01226-17
Lemire, Adams, Kermani-Arab, Bakke, Sakai et al., 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro, J Immunol
Leow, Simpson, Cursons, Karalus, Hancox, Vitamin D, innate immunity and outcomes in community acquired pneumonia, Respirology, doi:10.1111/j.1440-1843.2011.01924.x
Liu, Stenger, Li, Wenzel, Tan et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science, doi:10.1126/science.1123933
Lucidarme, Messai, Mazzoni, Arcade, Cheyron, Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study, Intensive Care Med, doi:10.1007/s00134-010-1875-8
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Mckinney, Bailey, Garrett, Peiris, Manning et al., Relationship between vitamin D status and ICU outcomes in veterans, J Am Med Dir Assoc, doi:10.1016/j.jamda.2010.04.004
Mehta, Mcauley, Brown, Sanchez, Tattersall et al., and HLH Across Speciality Collaboration UK. COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, doi:10.1016/S0140-6736(20)30628-0
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D status and other clinical characteristics with COVID-19 test results, JAMA Netw Open, doi:10.1001/jamanetworkopen.2020.19722
Moore, June, Cytokine release syndrome in severe COVID-19, Science, doi:10.1126/science.abb8925
Munshi, Hussein, Toraih, Elshazli, Jardak et al., Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J Med Virol, doi:10.1002/jmv.26360
Olliver, Spelmink, Hiew, Meyer-Hoffert, Henriques-Normark et al., Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae, J Infect Dis, doi:10.1093/infdis/jit355
Parekh, Thickett, Turner, Vitamin D deficiency and acute lung injury, Inflamm Allergy Drug Targets, doi:10.2174/18715281113129990049
Pearce, Cheetham, Diagnosis and management of vitamin D deficiency, BMJ, doi:10.1136/bmj.b5664
Remmelts, Van De Garde, Meijvis, Peelen, Damoiseaux et al., Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia, Clin Infect Dis, doi:10.1093/cid/cis751
Schwalfenberg, A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency, Mol Nutr Food Res, doi:10.1002/mnfr.201000174
Scragg, Stewart, Waayer, Lawes, Toop et al., Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial, JAMA Cardiol, doi:10.1001/jamacardio.2017.0175
Shi, Liu, Yao, Xing, Zhao et al., Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system, Sci Rep, doi:10.1038/s41598-017-03474-6
Stokes, Zambrano, Anderson, Marder, Raz et al., Coronavirus Disease 2019 Case Surveillance: United States, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm6924e2
Tartof, Qian, Hong, Wei, Nadjafi et al., Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization, Ann Intern Med, doi:10.7326/M20-3742
Urashima, Segawa, Okazaki, Kurihara, Wada et al., Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, Am J Clin Nutr, doi:10.3945/ajcn.2009.29094
Venkatram, Chilimuri, Adrish, Salako, Patel et al., Vitamin D deficiency is associated with mortality in the medical intensive care unit, Crit Care, doi:10.1186/cc10585
Vu Cković, Van Rein, Cannegieter, Rosendaal, Lijfering, Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study, Am J Clin Nutr, doi:10.3945/ajcn.114.095398
Wei, Christakos, Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D, Nutrients, doi:10.3390/nu7105392
Wu, He, Low vitamin D levels are associated with the development of deep venous thromboembolic events in patients with ischemic stroke, Clin Appl Thromb Hemost, doi:10.1177/1076029618786574
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol Med Rep, doi:10.3892/mmr.2017.7546
Yang, Zheng, Gou, Pu, Chen et al., 2: a systematic review and meta-analysis
Zdrenghea, Makrinioti, Bagacean, Bush, Johnston et al., Vitamin D modulation of innate immune responses to respiratory viral infections, Rev Med Virol, doi:10.1002/rmv.1909
Zhang, Leung, Richers, Liu, Remigio et al., Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1, J Immunol, doi:10.4049/jimmunol.1102412
Zhang, Wan, Sun, Kan, Wang, Association between vitamin D deficiency and mortality in critically ill adult patients: a meta-analysis of cohort studies, Crit Care, doi:10.1186/s13054-014-0684-9
Zhang, Wu, Li, Zhao, Gq, Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality, Int J Antimicrob Agents, doi:10.1016/j.ijantimicag.2020.105954
Zhou, Du, Huang, Wang, Shi et al., Preventive effects of vitamin D on seasonal influenza A in infants: a multicenter, randomized, open, controlled clinical trial, Pediatr Infect Dis J, doi:10.1097/INF.0000000000001890
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit